NCT00089557终止2 期
An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain
NeurogesX0 个研究点开始时间: 2004年8月9日最近更新:
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 终止
- 发起方
研究概览
简要总结
This study is an open-label, multicenter, extension study for subjects who completed NeurogesX Study C111 and received treatment with NGX-4010 (Capsaicin Patch) within 12 weeks (up to +7days) before entry into Study C114
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Key Eligibility Criteria:
- •Must have completed NeurogesX Study C111 and received treatment with NGX-4010 (Capsaicin Patch) within 12 weeks (up to +7 days) before entry into Study C
- •Demonstrated adherence to protocol requirements during Study C111, and willing and able to comply with protocol requirements for the duration of the study participation.
- •Must not have had any serious adverse experience since enrollment in Study C111, whether or not considered to be study drug-related.
- •Must have intact skin at the treatment area.
- •Must be prepared to remain on the same pain medications at the same doses as before the study for the entire duration of the study (36 weeks).
- •Must not use topical pain medications on painful areas.
- •Must be at least 18 years old, not pregnant, and able to take care of self independently, with only occasional assistance if needed.
- •No history or current problem with substance abuse.
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy (HIV-AN) or Postherpetic Neuralgia (PHN)NeuralgiaPainPeripheral Nervous System DiseasesHerpes ZosterHIV InfectionsNCT00233155NeurogesX100
终止
2 期
A Clinical Study to Test Long Term Safety of GLPG1690 for Patients With Systemic SclerosisSystemic SclerosisNCT03976648Galapagos NV31
已完成
3 期
Study of NGX-4010 for the Treatment of Postherpetic NeuralgiaPeripheral Nervous System DiseasesPainNeuralgiaShinglesHerpes ZosterNCT00300222NeurogesX400
已完成
3 期
Controlled Study of NGX-4010 for the Treatment of Postherpetic NeuralgiaNeuralgiaPainPeripheral Nervous System DiseasesHerpes ZosterNCT00068081NeurogesX150
已完成
4 期
Study Evaluating the Combination of Etanercept and Methotrexate in Rheumatoid Arthritis SubjectsRheumatoid ArthritisNCT00252668Wyeth is now a wholly owned subsidiary of Pfizer300